Effectiveness of BBG

Phase 2

• Conditions: Cataract, Vitreoretinal diseases; Cataract, macular hole, macular edema; C11.510.245, C11.768.740, C11.768.585.439.245

• Registration Number: JPRN-jRCTs021180004
• Lead Sponsor: Abe Samae

Brief Summary

Surgery with intraocular staining with Brilliant Blue G significantly improved postoperative visual acuity and macular retinal morphology.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-13
• Study Completion: 2021-06-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 187

Inclusion Criteria

Needs of use of Brilliant blue G in cataract or vitreous surgery

Exclusion Criteria

Without severe ocular infections

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual acuity

Secondary Outcome Measures

Name	Time	Method
Retinal morphological changes measured byoOptical coherence tomography (OCT)